2021
DOI: 10.1159/000515013
|View full text |Cite
|
Sign up to set email alerts
|

Ultrasound Cycloplasty in Chinese Glaucoma Patients: Results of a 6-Month Prospective Clinical Study

Abstract: Purpose: The aim of this study was to evaluate the short-term efficacy and safety of ultrasound cycloplasty (UCP) procedure in Chinese glaucoma patients. Methods: As a single-centre, prospective, non-comparative study, 23 eyes of 23 patients suffering from glaucoma with uncontrolled intraocular pressure (IOP) ≥ 21 mmHg underwent a multi-dose UCP treatment with the activations of 6, 8 or10 sectors. Types of glaucoma include primary open-angle glaucoma (POAG) (7/23), primary angle closure glaucoma (PACG) (9/23) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…There is published evidence of the possibility of retreating patients with early and late IOP increase with a second UCP procedure to achieve a greater IOP decrease while maintaining the same safety profile as the first procedure [23,27,28]. Additionally, a new version of the probe is now available, allowing an increased circumference of treated ciliary body (eight or ten instead of six sectors treated); this device achieved significant IOP control with a reduction in medication number in the Chinese population [33,34]. Another option that has been evaluated with encouraging results is association of UCP and phacoemulsification in the case of coexisting cataract with significant lowering of IOP and reduction in antiglaucoma medications [35].…”
Section: Discussionmentioning
confidence: 99%
“…There is published evidence of the possibility of retreating patients with early and late IOP increase with a second UCP procedure to achieve a greater IOP decrease while maintaining the same safety profile as the first procedure [23,27,28]. Additionally, a new version of the probe is now available, allowing an increased circumference of treated ciliary body (eight or ten instead of six sectors treated); this device achieved significant IOP control with a reduction in medication number in the Chinese population [33,34]. Another option that has been evaluated with encouraging results is association of UCP and phacoemulsification in the case of coexisting cataract with significant lowering of IOP and reduction in antiglaucoma medications [35].…”
Section: Discussionmentioning
confidence: 99%